Journal Information
Vol. 19. Issue 2.
Pages 119 (February 2023)
Share
Share
Download PDF
More article options
Vol. 19. Issue 2.
Pages 119 (February 2023)
Letter to the Editor
Full text access
Long COVID-19 and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Correspondence
COVID-19 largo y encefalomielitis miálgica/síndrome de fatiga crónica: correspondencia
Visits
4548
Rujittika Mungmunpuntipantipa,
Corresponding author
rujittika@gmail.com

Corresponding author.
, Viroj Wiwanitkitb
a Private Academic Consultant, Bangkok, Thailand
b Dr DY Patil University, Pune, India
This item has received
Article information
Full Text
Bibliography
Download PDF
Statistics
Full Text
Dear Editor:

We would like to share ideas on the publication “Long COVID-19 and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): similarities and differences of two peas in a pod.1” Long COVID-19 should be treated as a public health emergency, according to Qanneta. Real prevalence, phenotypes, risk factors, viable therapies, and potential differences with ME/CFS and other overlapping clinical entities must all be determined by well-conducted research.1 We concur that post-COVID issues could occur and that long-term COVID is currently a significant worldwide health issue. From asymptomatic to life-threatening clinical situations, COVID-19 exhibits a broad spectrum of clinical symptoms.2 The main COVID-19 symptom may also be connected to the existence of long-COVID-19. Additionally, not all clinical problems are brought on by COVID-19 recovery. The primary COVID-19 symptom may also be associated to long-COVID-19. Additionally, COVID-19 recovery does not cause all clinical problems. The clinical problems brought on by other medical conditions must be eliminated, even though the current study may give a true impression of prevalence. For instance, even after COVID-19, there remains a risk of developing another severe common disease, such influenza, necessitating the use of preventative measures.3 Therefore, additional medical issues may impede the clinical manifestation. In circumstances where it is practical, a more detailed investigation of the relationships between pre-COVID-19 health data and post-COVID-19 concerns may be possible.

Funding

None.

Conflict of interest

None.

References
[1]
R. Qanneta.
Long COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome: similarities and differences of two peas in a pod.
[2]
B. Joob, V. Wiwanitkit.
Letter to the Editor: coronavirus disease 2019 (COVID-19). Infectivity, and the incubation period.
J Prev Med Public Health, 53 (2020), pp. 70
[3]
H. Froese, A.G. A Prempeh.
Mask use to curtail influenza in a post-COVID-19 world: modeling study.
JMIRx Med, 3 (2022), pp. e31955
Copyright © 2022. Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología
Idiomas
Reumatología Clínica (English Edition)
Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?